Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Neurocrine Biosciences Inc Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $2.14 Million - $2.34 Million	-16,344 Reduced 57.42%	12,122 $1.67 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $1.3 Million - $1.43 Million	9,955 Added 53.78%	28,466 $3.93 Million
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $208,851 - $261,404	-1,969 Reduced 9.61%	18,511 $2.44 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $1.86 Million - $2.32 Million	-19,821 Reduced 49.18%	20,480 $2.3 Million
Q2 2023 May 17, 2024	BUY	$89.53 - $104.87 $1.06 Million - $1.24 Million	11,835 Added 41.58%	40,301 $3.8 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $857,249 - $1 Million	-9,575 Reduced 19.2%	40,301 $3.8 Million
Q1 2023 May 17, 2024	SELL	$94.11 - $123.02 $213,723 - $279,378	-2,271 Reduced 4.35%	49,876 $5.05 Million
Q1 2023 May 15, 2023	SELL	$94.11 - $123.02 $213,723 - $279,378	-2,271 Reduced 4.35%	49,876 $5.05 Million
Q4 2022 May 17, 2024	BUY	$106.72 - $127.06 $2.53 Million - $3.01 Million	23,681 Added 83.19%	52,147 $6.23 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $1.81 Million - $2.15 Million	16,943 Added 48.13%	52,147 $6.23 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $2.16 Million - $2.54 Million	23,516 Added 201.2%	35,204 $3.74 Million
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $385,361 - $504,294	-5,319 Reduced 31.28%	11,688 $1.1 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $980,013 - $1.31 Million	12,304 Added 261.62%	17,007 $1.44 Million
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $405,304 - $465,738	4,703 New	4,703 $451,000
Q2 2018 Aug 14, 2018	SELL	$75.3 - $105.99 $4.57 Million - $6.43 Million	-60,700 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $4.61 Million - $5.61 Million	60,700 New	60,700 $5.03 Million

Others Institutions Holding NBIX

# of Institutions

638

Shares Held

93.8M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$2.15 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.52 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$782 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$391 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$283 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account